Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Brazil reports first research-targeted "embryo production" data

This article was originally published in Clinica

Executive Summary

Around 27,000 embryos were eligible for donation to Brazil's national stem cell research programme, according to the first annual embryo registration exercise, involving the country's 120 IVF clinics. By the first deadline (August 10), which sought to survey all embryos created until the end of 2007, some 50,000 were registered with the "national embryo production system" (SisEmbrio) by 50 clinics, said the Anvisa agency, which operates it. Anvisa thus estimates the total number of embryos to have been around 110,000. Only embryos that are unviable (genetically or morphologically defective) and supernumerary embryos stored for at least three years are eligible for research, subject to their being donated by the couple.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT043354

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel